These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38841196)
1. Improving access to screening and treatment of hepatocellular carcinoma in the United States. Davis JPE; Rabiee A Clin Liver Dis (Hoboken); 2024; 23(1):e0219. PubMed ID: 38841196 [No Abstract] [Full Text] [Related]
2. Is Screening for Hepatocellular Carcinoma Effective? Lee RM; Russell MC Adv Surg; 2023 Sep; 57(1):73-86. PubMed ID: 37536863 [TBL] [Abstract][Full Text] [Related]
3. [Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma]. Chinese Preventive Medicine Association, Society of Prevention and Control of Infectious Diseases Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):942-947. PubMed ID: 34814388 [TBL] [Abstract][Full Text] [Related]
4. An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma. Kronenfeld JP; Goel N J Hepatocell Carcinoma; 2021; 8():1209-1219. PubMed ID: 34611524 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Screening Associated with Early Tumor Detection and Improved Survival Among Patients with Cirrhosis in the US. Singal AG; Mittal S; Yerokun OA; Ahn C; Marrero JA; Yopp AC; Parikh ND; Scaglione SJ Am J Med; 2017 Sep; 130(9):1099-1106.e1. PubMed ID: 28213044 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States. Muhammad H; Gurakar M; Ting PS; Alsughayer AM; Luu H; Zaffar D; Alqahtani S; Bonder A; Gurakar A; Saberi B Exp Clin Transplant; 2022 Mar; 20(3):279-284. PubMed ID: 35352634 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of a nurse-led decision counselling programme on hepatocellular carcinoma screening uptake among patients with hepatitis B: A randomised controlled trial. Li C; Lu X; Xu J; Gao F; Lee E; Chan CWH Int J Nurs Stud; 2023 Dec; 148():104610. PubMed ID: 37801936 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: diagnosis and treatment. Befeler AS; Di Bisceglie AM Gastroenterology; 2002 May; 122(6):1609-19. PubMed ID: 12016426 [TBL] [Abstract][Full Text] [Related]
9. [Care pathway of patients with hepatocellular carcinoma in France: State of play in 2017]. Costentin C; Ganne-Carrié N; Rousseau B; Gérolami R; Barbare JC Bull Cancer; 2017 Sep; 104(9):752-761. PubMed ID: 28751065 [TBL] [Abstract][Full Text] [Related]
10. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Di Bisceglie AM; Order SE; Klein JL; Waggoner JG; Sjogren MH; Kuo G; Houghton M; Choo QL; Hoofnagle JH Am J Gastroenterol; 1991 Mar; 86(3):335-8. PubMed ID: 1847790 [TBL] [Abstract][Full Text] [Related]
11. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. El-Serag HB; Davila JA; Petersen NJ; McGlynn KA Ann Intern Med; 2003 Nov; 139(10):817-23. PubMed ID: 14623619 [TBL] [Abstract][Full Text] [Related]
12. Bibliometric study of immunotherapy for hepatocellular carcinoma. Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H Front Immunol; 2023; 14():1210802. PubMed ID: 37600802 [TBL] [Abstract][Full Text] [Related]
13. Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States. Cadier B; Bulsei J; Nahon P; Seror O; Laurent A; Rosa I; Layese R; Costentin C; Cagnot C; Durand-Zaleski I; Chevreul K; Hepatology; 2017 Apr; 65(4):1237-1248. PubMed ID: 28176349 [TBL] [Abstract][Full Text] [Related]
14. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Chalasani N; Said A; Ness R; Hoen H; Lumeng L Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554 [TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Capocaccia R; Sant M; Berrino F; Simonetti A; Santi V; Trevisani F; Am J Gastroenterol; 2007 Aug; 102(8):1661-70; quiz 1660, 1671. PubMed ID: 17555459 [TBL] [Abstract][Full Text] [Related]
16. The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States. Durham DP; Skrip LA; Bruce RD; Vilarinho S; Elbasha EH; Galvani AP; Townsend JP Clin Infect Dis; 2016 Feb; 62(3):298-304. PubMed ID: 26628566 [TBL] [Abstract][Full Text] [Related]
17. Recent developments in screening, diagnosis and surgical treatment of hepatocellular carcinoma. IJzermans JN; Bac DJ Scand J Gastroenterol Suppl; 1997; 223():50-4. PubMed ID: 9200307 [TBL] [Abstract][Full Text] [Related]
18. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy. Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L J Clin Nurs; 2018 Jul; 27(13-14):2673-2683. PubMed ID: 29603817 [TBL] [Abstract][Full Text] [Related]
19. Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review. Ha J; Chaudhri A; Avirineni A; Pan JJ Biomark Res; 2017; 5():15. PubMed ID: 28439416 [TBL] [Abstract][Full Text] [Related]
20. A cost-effectiveness analysis of universal hepatitis C screening in all United States pregnancies. Susich M; Hersh AR; Greiner K; Chaiken SR; Caughey AB J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7381-7388. PubMed ID: 34392786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]